Form 4 for CRMD CorMedix Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-04-01 · accession 0001213900-25-027598 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-02 | 2025-04-01 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +59.2K | 530.7K | +13% | +$200.0K |
| D | 2025-04-02 | 2025-04-01 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $0.00 | -59.2K | 440.8K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | M | A | 59,170 | $3.38 | 530,721 | D | — | — | (F1) The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made. |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-04-01 | M | D | 59,170 | $0.00 | 440,830 | D | $3.38 · — to 2032-05-09 | 59,170 Common Stock | (F2) These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |